©The Author(s) 2026.
World J Cardiol. Feb 26, 2026; 18(2): 113358
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.113358
Published online Feb 26, 2026. doi: 10.4330/wjc.v18.i2.113358
Figure 2 Histopathology of lipopolysaccharide-induced myocardial injury and protection by melatonin.
Representative hematoxylin and eosin-stained myocardial sections from control, lipopolysaccharide (LPS), LPS plus ferrostatin-1, and LPS plus melatonin groups 24 hours after LPS injection. The LPS group shows interstitial edema, hemorrhage/congestion, myofibrillar disruption, and inflammatory cell infiltration; these changes are attenuated in LPS plus ferrostatin-1 and LPS plus melatonin. Representative images from n = 6 mice per group; scale bar = 20 μm. LPS: Lipopolysaccharide; LPS + Mel: Lipopolysaccharide plus melatonin; LPS + Fer-1: Lipopolysaccharide plus ferrostatin-1.
- Citation: Zeng M, Li Q, Li L, Xiang CF, Wang YJ. Melatonin regulates Sirt1/Nrf2/GPX4 pathway to inhibit ferroptosis and alleviate myocardial injury caused by sepsis. World J Cardiol 2026; 18(2): 113358
- URL: https://www.wjgnet.com/1949-8462/full/v18/i2/113358.htm
- DOI: https://dx.doi.org/10.4330/wjc.v18.i2.113358